Stuart J. Forbes

2001–2025 年に発表

113
論文数
22,238
被引用数
76
h 指数
108
i10 指数

被引用数

Stuart J. Forbes の年別被引用数1996 年: 被引用 5 件2001 年: 被引用 5 件2002 年: 被引用 16 件2003 年: 被引用 47 件2004 年: 被引用 49 件2005 年: 被引用 86 件2006 年: 被引用 112 件2007 年: 被引用 135 件2008 年: 被引用 122 件2009 年: 被引用 117 件2010 年: 被引用 103 件2011 年: 被引用 143 件2012 年: 被引用 142 件2013 年: 被引用 222 件2014 年: 被引用 216 件2015 年: 被引用 212 件2016 年: 被引用 289 件2017 年: 被引用 278 件2018 年: 被引用 326 件2019 年: 被引用 866 件2020 年: 被引用 984 件2021 年: 被引用 1,079 件2022 年: 被引用 917 件2023 年: 被引用 793 件2024 年: 被引用 1,056 件2025 年: 被引用 642 件2026 年: 被引用 18 件1997〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,344 件、この内訳の 22.5%中国: 引用元論文 1,879 件、この内訳の 18.1%イギリス: 引用元論文 848 件、この内訳の 8.2%ドイツ: 引用元論文 671 件、この内訳の 6.4%イタリア: 引用元論文 480 件、この内訳の 4.6%日本: 引用元論文 412 件、この内訳の 4%スペイン: 引用元論文 311 件、この内訳の 3%オランダ: 引用元論文 285 件、この内訳の 2.7%フランス: 引用元論文 273 件、この内訳の 2.6%オーストラリア: 引用元論文 225 件、この内訳の 2.2%カナダ: 引用元論文 198 件、この内訳の 1.9%韓国: 引用元論文 183 件、この内訳の 1.8%
0%22.5%その他 22%

分野

  • Medicine59.9%
  • Biochemistry, Genetics and Molecular Biology21.4%
  • Immunology and Microbiology11.3%
  • Engineering2.7%
  • Neuroscience1.2%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • その他2.4%

トピック

  • Liver physiology and pathology8.3%
  • Liver Disease Diagnosis and Treatment4.6%
  • Immune cells in cancer3.3%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.8%
  • Mesenchymal stem cell research2.5%
  • Tissue Engineering and Regenerative Medicine2.2%
  • その他76.3%

共著者

全論文

検索で開く
  1. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2016 被引用: 1,398

  2. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis

    著者: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 被引用: 985

  3. Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hiromi Chikada, Shuyong Wang, Seon Ju Mun, Myung Jin Son, Tamer T. Önder, James L. Boyer, Toshiro Sato, Nikitas Georgakopoulos, André Marcelo Conceição Meneses, Laura Broutier, Luke Boulter, Dominic Grün, Jan N.M. IJzermans, Benedetta Artegiani, Ruben van Boxtel, Ewart Kuijk, Guido Carpino, Gary Peltz, Jesús M. Bañales, Nancy Kwan Man, Luigi Aloia, Nicholas F. LaRusso, Gregory A. George, Casey A. Rimland, George C. Yeoh, Anne Grappin-Botton, Daniel E. Stange, Nicole Prior, Janina E. E. Tirnitz‐Parker, Emma Andersson, Chiara Braconi, Nicholas R. F. Hannan, Wei‐Yu Lu, Stephen C. Strom, Pau Sancho‐Bru, Shinichiro Ogawa, Vincenzo Corbo, Madeline A. Lancaster, Huili Hu, Sabine A. Fuchs, Delilah Hendriks, Helmuth Gehart, Eelco de Koning, Frédéric Lemaigre, Stuart J. Forbes, Weng Chuan Peng, Meritxell Huch, Takanori Takebe, Ludovic Vallier, Hans Clevers, Luc J. W. van der Laan, Bart Spee - Cell stem cell 2021 被引用: 310

  4. Liver regeneration and inflammation: from fundamental science to clinical applications

    著者: , , , - Nature Reviews Molecular Cell Biology 2021 被引用: 290

  5. Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells

    著者: , , , , , , , , , - Hepatology 2010 被引用: 735

  6. Cellular senescence inhibits renal regeneration after injury in mice, with senolytic treatment promoting repair

    著者: , , , , , , , , , , , , - Science Translational Medicine 2021 被引用: 203

  7. TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuel Serrano, Tania Roskams, Owen J. Sansom, Stuart J. Forbes - Science Translational Medicine 2018 被引用: 264

  8. Preparing the ground for tissue regeneration: from mechanism to therapy

    著者: , - Nature Medicine 2014 被引用: 581

  9. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma

    著者: , , , , , , , , , , , - Journal of Hepatology 2014 被引用: 493

  10. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

    著者: , , , , , , , , - Journal of Clinical Investigation 2005 被引用: 1,427

  11. Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration

    著者: , , , , , , , , , , , , , - Nature 2017 被引用: 532

  12. Safety profile of autologous macrophage therapy for liver cirrhosis

    著者: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2019 被引用: 201

  13. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease

    著者: , , , , , , , , , , , , , , - Nature Medicine 2012 被引用: 730

  14. Alternatively activated macrophages promote resolution of necrosis following acute liver injury

    著者: , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 226

  15. Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis

    著者: , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2011 被引用: 473

  16. Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3

    著者: , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2011 被引用: 521

  17. Liver regeneration — mechanisms and models to clinical application

    著者: , - Nature Reviews Gastroenterology & Hepatology 2016 被引用: 414

  18. Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF

    著者: , , , , , , , , , , , , , - Journal of Hepatology 2022 被引用: 93

  19. The RSPO–LGR4/5–ZNRF3/RNF43 module controls liver zonation and size

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stuart J. Forbes, Heinz Ruffner, Jan S. Tchorz - Nature Cell Biology 2016 被引用: 362

  20. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tom Luedde, Mathias Heikenwälder, Verena Keitel - Journal of Hepatology 2021 被引用: 114

  21. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function

    著者: , , , , , , , , , , - Hepatology 2011 被引用: 340

  22. Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lara Campana, Philip Starkey Lewis, A. John Simpson, David H. Dockrell, Jürgen Schwarze, Nikhil Hirani, Peter J. Ratcliffe, Christopher W. Pugh, Kamil R. Kranc, Stuart J. Forbes, Moira K. B. Whyte, Sarah R. Walmsley - Nature Immunology 2022 被引用: 80

  23. Hepatic progenitor cells of biliary origin with liver repopulation capacity

    著者: , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2015 被引用: 500

  24. Recruited macrophages that colonize the post-inflammatory peritoneal niche convert into functionally divergent resident cells

    著者: , , , , , , - Nature Communications 2021 被引用: 146